Mene Pangalos | search
Click here to view Mene Pangalos news from 60+ newspapers.
Bookmark or Share- Fellow Detail Page | Royal SocietySir Menelas Pangalos FMedSci FRS Professor Sir Menelas (Mene) Pangalos has made outstanding contributions to drug discovery and life science across multiple pharmaceutical companies; leading scientific and cultural R&D transformation, pioneering private-public partnerships, developing new scientific talent and guiding UK life science strategy.
- AstraZeneca’s drugs chief Sir Mene Pangalos cures his work-life balanceMonday September 11 2023, 12.01am, The Times. Sir Mene Pangalos, the executive vice-president, biopharmaceuticals R&D, at AstraZeneca is preparing to leave the company after a transformational...
- AstraZeneca appoints Sharon Barr as Executive Vice President ...PUBLISHED 28 July 2023. AstraZeneca today announced the appointment of Sharon Barr as Executive Vice President, BioPharmaceuticals R&D. Sharon will succeed Mene Pangalos, who is retiring and will step down from his role early next year, after almost fourteen years with the company and an illustrious 35-year career.
- Sir Menelas Pangalos | The Academy of Medical SciencesPhysics, chemistry, biochemistry, structural biology, mathematical sciences including statistics, informatics, imaging and engineering applied to biomedicine. Dr Mene Pangalos is Executive Vice President of AstraZeneca’s Innovative Medicines and Early Development Biotech Unit.
- Mene Pangalos - Clare HallSir Mene Pangalos, PhD FRSB FMedSci, was appointed by AstraZeneca as Executive Vice-President, R&D BioPharmaceuticals in January 2019. He is responsible for BioPharmaceutical R&D from discovery through to late-stage development covering Cardiovascular, Renal, Metabolism, Respiratory, Inflammation, Autoimmune, Microbial Science and Neuroscience ...
More
